• 제목/요약/키워드: Fructus Ponciri Seu Aurantii

검색결과 4건 처리시간 0.02초

동의보감(東醫寶鑑) 중(中) 지각(枳殼)이 주약(主藥)으로 배오(配伍)된 방제(方劑)의 활용(活用)에 대한 고찰(考察) (A study on Applications of prescriptions including Fructus Ponciri Seu Aurantii as a main component in Dongeuibogam)

  • 유승훈;임영환;유승열;윤용갑
    • 대한한의학방제학회지
    • /
    • 제16권1호
    • /
    • pp.15-27
    • /
    • 2008
  • This report describes 46 studies related to the use of Fructus Ponciri Seu Aurantii main blended prescriptions from Dongeuibogam. The following conclusions were reached through investigations on the prescriptions that use Fructus Ponciri Seu Aurantii as a key ingredient. 1. 19.6% of feces recorded the largest number of clinical frequency of the prescriptions in therapeutic use when Fructus Ponciri Seu Aurantii was taken as a monarch drug in prescriptions. In addition, 13.0% of each of a cough and an abdominal mass with distention and pain ranked second. 2. Prescriptions that utilize Fructus Ponciri Seu Aurantii as the main ingredient are used in the treatmeant of 5 diseases related to each of feces and an abdominal mass with distention and pain, and they are also used for treating different types of diseases related to the following ; a cough, a chest, ribs, eyes, the fullness in the chest, Qi, skin areas. 3. In the view of the causative agent of a disease, the prescriptions which are compounded with Fructus Ponciri Seu Aurantii as a monarch drug are related to endogenous agents such as seven emotion, food, deficiency, exogenous agents such as wind-cold pathogen, heat and non-endo-exopathogcnic factors like diseases due to external factors, poison. And in the view of the pathology of a disease, they are applied to the viscera pathology related to the lung, the spleen and stomach, the pathology of Qi and blood related to the reversed flow of Qi, the congestion of Qi, the deficiency of blood, the obstruction of Qi and blood, and the pathology about the retention of phlegm and fluid related to phlegm stagnation. 4. The dosage of Fructus Ponciri Seu Aurantii is 1.25pun(about 0,47g) to 2jeon(about 7.5g), however 1jeon(about 3.75g) has been taken the most for clinical application. 5. We can find out that according to herbs or prescriptions blended with itself, Fructus Ponciri Seu Aurantii makes a variety of functions to penetrate and remove stagnation, regulate Qi flow, relieve stagnation, expell wind and get rid of pain.

  • PDF

XO/HX에 의해 손상된 배양 심근세포에 대한 지실해백계지탕과 구성약물 추출물의 방어효과 (Protective Effects of Jisilhaebaekgyeji-tang and Constituents Extract on Cultured Rat Myocardial Cell treated by XO/HX)

  • 장승호;권강범;김인수;강길성;김인규;김인섭;류도곤
    • 동의생리병리학회지
    • /
    • 제17권4호
    • /
    • pp.952-957
    • /
    • 2003
  • To certify the protective effect of herbal medicine against oxygen free radical-induced myocardiotoxicity, cytotoxicity was measured using LDH activity and TBARS assay in the presence of Jisilhaebaekgyejitang(JHGT) extracts or single constituents of this prescription, In the present study, xanthine oxidase/hypoxanthine (XO/HX) resulted in a cell damage such as increases in LDH activity in culture medium and lipid peroxidation in cultured myocardial cells. In the effect of JHGT extract and its single constituents, which are Fructus Ponciri Seu Aurantii Immaturus (FPSAI), Cortex Magnoliae Officinalis (CMO), Bulbus Allii Macrostemi (BAM), Ramulus Cinnamomi (RC) and Fructus Trichosanthis (FT), they showed the prevention from the XO/HX-induced cardiotoxicity by the decrease of LDH activity and lipid peroxidation. From these results, they show that XO/HX is cardiotoxic in cultured myocardial cells derived from neonatal rat, and it suggests that JHGT, FPSAI, PT, CMO, BAM, RC and FT extracts are positively effective in the blocking in XO/HX-induced cardiotoxicity.

동의보감(東醫寶鑑) 중(中) 행인(杏仁)이 주약(主藥)으로 배오(配伍)된 방제(方劑)의 활용(活用)에 대한 고찰(考察) (A Study on Application of Semen Armeniacae Amarum Main Blended Prescription from Donguibogam)

  • 전영균;국윤범;김윤경;윤용갑
    • 대한한의학방제학회지
    • /
    • 제12권2호
    • /
    • pp.31-46
    • /
    • 2004
  • This report describes 61 studies related to the use of Semen Armeniacae Amarum main blended prescriptions from Donguibogam. The following conclusions were reached through investigations on the prescriptions that use Semen Armeniacae Amarum as a key ingredient. Semen Armeniacae Amarum blended prescriptions are utilized for 16 therapeutic purposes, for example, in symptoms of cough, excrements, wind, and pediatrics. In particular, 52.46% of the prescriptions appear in the chapter of cough, and 9.84% of those appear in the chapter of excrements. Prescriptions that utilize Semen Armeniacae Amarum as the main ingredient are used in the treatment of cough, asthma, lung disease, and constipation, and they are also used for treating 15 different types of diseases. Semen Armeniacae Amarum is used in pathogenic factors such as wind, wind with cold, and wind with moisture, in pathologies related to lung and digestive systems, and in those related to weakness, extravasated blood, and alcoholic drink-food. The actual amount of Semen Armeniacae Amarum blended has ranged at a wide variety of amounts from 5 pun to 5 don. 47.62% of the prescriptions used 1 don. When Semen Armeniacae Amarum is combined with base prescriptions such as Samyotang, Banhaenghwan, ljintang, etc and Herba Ephedrae, Rhizoma Pinelliae, and Pericarpium Citri Reticulatae, it ceases cough and asthma. In addition, when Semen Armeniacae Amarum is combined with Fructus Ponciri Seu Aurantii and Fructus Cannabis, it brings a relief in constipation.

  • PDF

한방소재 화장품의 아토피 피부염 개선 효과 (The Enhancing Effect of Atopic Dermatitis by cosmetics containing estern medical herbs)

  • 강신정;김애정;이연희;이명숙;정경희;조남지
    • 한국산학기술학회논문지
    • /
    • 제10권11호
    • /
    • pp.3500-3505
    • /
    • 2009
  • 한방소재를 이용한 화장품이 아토피피부염을 개선하는지를 알아보고자, 중등증의 아토피 피부염환자 16명을 대상으로, 진경한방컴플렉스(감초, 백지, 작약, 지실, 천궁, 갈근, 현호색), 편백수, 녹차, 황기, 홍삼, 당밀발효액, 사과 발효여과물이 함유된 화장수와 크림을 하루에 3회 피부염병변에 6주간 도포하도록 하였다. 그 결과 SCORAD 지수는 $26.9{\pm}11.8$에서 $14.9{\pm}9.7$로 감소(p<0.05), Total IgE(IU/mL)는 $641.9{\pm}1294.6$에서 $565.8{\pm}1076.8$로 감소, Eosinophil의 수(ug/dL)는 $246.7{\pm}203.5$에서 $203.3{\pm}130.7$로 감소하였다(p<0.05). 피부수분함유량은 $36.6{\pm}10.0$에서 $44.0{\pm}10.3$로 증가(p<0.01), 경피수분손실량(g/h/$m^2$)은 $16.7{\pm}5.1$에서 $15.4{\pm}8.7$로 감소(p<0.05)하였으며, 피부 pH는 약산성을 유지하였다. 또한 의사 및 환자의 총괄유효성 평가도 증가되었다.